UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The race to target MET exon 14 skipping alterations in non-small cell lung cancer: the Why, the How, the Who, the Unknown, and the Inevitable

Lung cancer (Amsterdam, Netherlands), 2017-01, Vol.103, p.27-37

2017

Volltextzugriff (PDF)

Anti–PD-1 Antibody Treatment and the Development of Acute Pulmonary Tuberculosis

Journal of thoracic oncology, 2016-12, Vol.11 (12), p.2048-2050

2016

Volltextzugriff (PDF)

Effect of drug metabolizing enzymes and transporters in Thai colorectal cancer patients treated with irinotecan-based chemotherapy

Scientific reports, 2020-08, Vol.10 (1), p.13486, Article 13486

2020

Volltextzugriff (PDF)

Cost-utility analysis of adjuvant trastuzumab therapy for HER2-positive early-stage breast cancer in the Philippines

BMC health services research, 2019-11, Vol.19 (1), p.874-874, Article 874

2019

Volltextzugriff (PDF)

Progress in the Management of Malignant Pleural Mesothelioma in 2017

Journal of thoracic oncology, 2018-05, Vol.13 (5), p.606-623

2018

Volltextzugriff (PDF)

CYP450 and drug efflux transporters polymorphism influence clinical outcomes of Thai osimertinib-treated non-small cell lung cancer patients

Frontiers in pharmacology, 2023-11, Vol.14, p.1222435-1222435

2023

Volltextzugriff (PDF)

Asian Thoracic Oncology Research Group Expert Consensus Statement on Optimal Management of Stage III NSCLC

Journal of thoracic oncology, 2020-03, Vol.15 (3), p.324-343

2020

Volltextzugriff (PDF)

Gastrointestinal microbiota profile and clinical correlations in advanced EGFR-WT and EGFR-mutant non-small cell lung cancer

BMC cancer, 2022-09, Vol.22 (1), p.1-963, Article 963

2022

Volltextzugriff (PDF)

Efficacy of First Line Systemic Chemotherapy and Multikinase Inhibitors in Advanced Hepatocellular Carcinoma: A Systematic Review and Network Meta-Analysis

Frontiers in oncology, 2021-03, Vol.11, p.654020-654020

2021

Volltextzugriff (PDF)

Exosomal microRNAs as potential biomarkers for osimertinib resistance of non-small cell lung cancer patients

Cancer biomarkers : section A of Disease markers, 2021-01, Vol.31 (3), p.281-294

2021

Volltextzugriff (PDF)

Efficacy of Combination Docetaxel and Nintedanib in Advanced Non-Small Cell Lung Cancer in Thailand: A Multicenter Study

Frontiers in oncology, 2021-04, Vol.11, p.572740-572740

2021

Volltextzugriff (PDF)

Effects of polymorphisms in the MTHFR gene on 5-FU hematological toxicity and efficacy in Thai colorectal cancer patients

Frontiers in oncology, 2022-07, Vol.12, p.916650-916650

2022

Volltextzugriff (PDF)

Asian Thoracic Oncology Research Group (ATORG) Expert Consensus Statement on MET Alterations in NSCLC: Diagnostic and Therapeutic Considerations

Clinical lung cancer, 2022-12, Vol.23 (8), p.670-685

2022

Volltextzugriff (PDF)

Determination of irinotecan, SN‐38 and SN‐38 glucuronide using HPLC/MS/MS: Application in a clinical pharmacokinetic and personalized medicine in colorectal cancer patients

Journal of clinical laboratory analysis, 2018-01, Vol.32 (1), p.n/a

2018

Volltextzugriff (PDF)

Correlation of UGT1A128 and 6 polymorphisms with irinotecan-induced neutropenia in Thai colorectal cancer patients

Drug metabolism and pharmacokinetics, 2016-02, Vol.31 (1), p.90-94

2016

Volltextzugriff (PDF)

Impact of Waiting Times on Mortality in Advanced Stage Non-Small Cell Lung Cancer: A 10-Year Retrospective Cohort Study in Thailand

Asian Pacific Journal of Cancer Prevention, 2023-10, Vol.24 (10), p.3419-3428

2023

Volltextzugriff (PDF)

Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC

The New England journal of medicine, 2020-01, Vol.382 (1), p.41-50

2020

Volltextzugriff (PDF)

CNS Response to Osimertinib Versus Standard Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients With Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer

Journal of clinical oncology, 2018-11, Vol.36 (33), p.JCO2018783118-3297

2018

Volltextzugriff (PDF)

Lung Cancer in Thailand

Journal of thoracic oncology, 2020-11, Vol.15 (11), p.1714-1721

2020

Volltextzugriff (PDF)

Extracellular Vesicles from EGFR T790M/L858R -mutant Non-small Cell Lung Cancer Promote Cancer Progression

Anticancer research, 2022-08, Vol.42 (8), p.3835-3844

2022

Volltextzugriff (PDF)

Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma

Journal of clinical oncology, 2018-01, Vol.36 (3), p.276-282

2018

Volltextzugriff (PDF)

Alectinib versus crizotinib in untreated Asian patients with anaplastic lymphoma kinase-positive non-small-cell lung cancer (ALESIA): a randomised phase 3 study

The lancet respiratory medicine, 2019-05, Vol.7 (5), p.437-446

2019

Volltextzugriff (PDF)

Correlation of clinical characteristics and immunologic profile of stage III NSCLC patients

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e20552-e20552

2021

Volltextzugriff (PDF)

Osimertinib versus Standard of Care EGFR TKI as First-Line Treatment in Patients with EGFRm Advanced NSCLC: FLAURA Asian Subset

Journal of thoracic oncology, 2019-01, Vol.14 (1), p.99-106

2019

Volltextzugriff (PDF)

1 – 25 von 67

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(62)
Mit Volltextzugriff
(58)

Publikationsform

Artikel
(66)
Dissertationen
(1)

Sprache

Englisch
(66)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Science & Technology
(44)
Life Sciences & Biomedicine
(43)
Oncology
(35)
Humans
(30)
Respiratory System
(17)
Lung Neoplasms - Drug Therapy
(14)
Female
(13)
Mutation
(13)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(12)
Lung Cancer
(12)
Middle Aged
(12)
Protein Kinase Inhibitors - Therapeutic Use
(12)
Lung Neoplasms - Pathology
(11)
Male
(11)
Aged
(10)
Adult
(9)
Lung Neoplasms - Genetics
(9)
Carcinoma, Non-Small-Cell Lung - Genetics
(8)
Carcinoma, Non-Small-Cell Lung - Pathology
(8)
Tumors
(8)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The race to target MET exon 14 skipping alterations in non-small cell lung cancer: the Why, the How, the Who, the Unknown, and the Inevitable

Anti–PD-1 Antibody Treatment and the Development of Acute Pulmonary Tuberculosis

Effect of drug metabolizing enzymes and transporters in Thai colorectal cancer patients treated with irinotecan-based chemotherapy

Cost-utility analysis of adjuvant trastuzumab therapy for HER2-positive early-stage breast cancer in the Philippines

Progress in the Management of Malignant Pleural Mesothelioma in 2017

CYP450 and drug efflux transporters polymorphism influence clinical outcomes of Thai osimertinib-treated non-small cell lung cancer patients

Asian Thoracic Oncology Research Group Expert Consensus Statement on Optimal Management of Stage III NSCLC

Gastrointestinal microbiota profile and clinical correlations in advanced EGFR-WT and EGFR-mutant non-small cell lung cancer

Efficacy of First Line Systemic Chemotherapy and Multikinase Inhibitors in Advanced Hepatocellular Carcinoma: A Systematic Review and Network Meta-Analysis

Exosomal microRNAs as potential biomarkers for osimertinib resistance of non-small cell lung cancer patients

Efficacy of Combination Docetaxel and Nintedanib in Advanced Non-Small Cell Lung Cancer in Thailand: A Multicenter Study

Effects of polymorphisms in the MTHFR gene on 5-FU hematological toxicity and efficacy in Thai colorectal cancer patients

Asian Thoracic Oncology Research Group (ATORG) Expert Consensus Statement on MET Alterations in NSCLC: Diagnostic and Therapeutic Considerations

Determination of irinotecan, SN‐38 and SN‐38 glucuronide using HPLC/MS/MS: Application in a clinical pharmacokinetic and personalized medicine in colorectal cancer patients

A Phase II Study of Osimertinib in Patients with Advanced-Stage Non-Small Cell Lung Cancer following Prior Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR TKI) Therapy with EGFR and T790M Mutations Detected in Plasma Circulating Tumour DNA (PLASMA Study)

Correlation of UGT1A128 and 6 polymorphisms with irinotecan-induced neutropenia in Thai colorectal cancer patients

Impact of Waiting Times on Mortality in Advanced Stage Non-Small Cell Lung Cancer: A 10-Year Retrospective Cohort Study in Thailand

Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC

CNS Response to Osimertinib Versus Standard Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients With Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer

Lung Cancer in Thailand

Extracellular Vesicles from EGFR T790M/L858R -mutant Non-small Cell Lung Cancer Promote Cancer Progression

Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma

Alectinib versus crizotinib in untreated Asian patients with anaplastic lymphoma kinase-positive non-small-cell lung cancer (ALESIA): a randomised phase 3 study

Correlation of clinical characteristics and immunologic profile of stage III NSCLC patients

Osimertinib versus Standard of Care EGFR TKI as First-Line Treatment in Patients with EGFRm Advanced NSCLC: FLAURA Asian Subset

Suchergebnisse filtern